Post-marketing surveillance is a systematic process for monitoring the safety and efficacy of pharmaceutical products and medical devices after they have been introduced to the market. This methodology involves the collection, analysis, and interpretation of real-world data from diverse patient populations to identify adverse events, assess long-term performance, and ensure continued product safety and effectiveness beyond the controlled environment of pre-market clinical trials.